E. S. SAYGILI Et Al. , "Is predicting metastatic phaeochromocytoma and paraganglioma still effective without methoxytyramine?," The Lancet Digital Health , vol.6, no.3, 2024
SAYGILI, E. S. Et Al. 2024. Is predicting metastatic phaeochromocytoma and paraganglioma still effective without methoxytyramine?. The Lancet Digital Health , vol.6, no.3 .
SAYGILI, E. S., Elhassan, Y. S., & Ronchi, C. L., (2024). Is predicting metastatic phaeochromocytoma and paraganglioma still effective without methoxytyramine?. The Lancet Digital Health , vol.6, no.3.
SAYGILI, EMRE, Yasir S Elhassan, And Cristina L Ronchi. "Is predicting metastatic phaeochromocytoma and paraganglioma still effective without methoxytyramine?," The Lancet Digital Health , vol.6, no.3, 2024
SAYGILI, EMRE S. Et Al. "Is predicting metastatic phaeochromocytoma and paraganglioma still effective without methoxytyramine?." The Lancet Digital Health , vol.6, no.3, 2024
SAYGILI, E. S. Elhassan, Y. S. And Ronchi, C. L. (2024) . "Is predicting metastatic phaeochromocytoma and paraganglioma still effective without methoxytyramine?." The Lancet Digital Health , vol.6, no.3.
@article{article, author={EMRE SEDAR SAYGILI Et Al. }, title={Is predicting metastatic phaeochromocytoma and paraganglioma still effective without methoxytyramine?}, journal={The Lancet Digital Health}, year=2024}